1,218
Participants
Start Date
October 31, 1995
Study Completion Date
August 31, 2008
Bicalutamide
150mg p.o. daily
Placebo
Research Site, Aalborg
Research Site, Charlottenlund
Research Site, Copenhagen
Research Site, Esbjerg
Research Site, Frederiksberg
Research Site, Frederikssund
Research Site, Glostrup Municipality
Research Site, Herlev
Research Site, Holbuk
Research Site, NYK BING Falster
Research Site, Odense
Research Site, Orhus
Research Site, Randers
Research Site, S Nderborg
Research Site, Helsinki
Research Site, Joensuu
Research Site, Kokkola
Research Site, Kuopio
Research Site, Lahti
Research Site, Lappeenranta
Research Site, OYS (oulu)
Research Site, Tampere
Research Site, Turku
Research Site, Bergen
Research Site, BODU
Research Site, Drammen
Research Site, Fredrikstad
Research Site, Harstad
Research Site, Kristiansand
Research Site, Lesund
Research Site, Levanger
Research Site, Lillehammer
Research Site, Oslo
Research Site, Porsgrunn
Research Site, Rud
Research Site, Stavanger
Research Site, Strummen
Research Site, Tromsu
Research Site, Trondheim
Research Site, Tunsberg
Research Site, Gothenburg
Research Site, Govle
Research Site, Helsingborg
Research Site, Hudiksvall
Research Site, Junkoping
Research Site, Kristinehamn
Research Site, Luleå
Research Site, Malmu
Research Site, Norrköping
Research Site, Stockholm
Research Site, Urebro
Research Site, Ustersund
Research Site, VoSTEROS
Research Site, Vostervik
Lead Sponsor
Scandinavian Prostate Cancer Group
NETWORK
AstraZeneca
INDUSTRY